MARKET

ANL

ANL

Adlai Nortye Ltd.
NASDAQ
10.01
-0.13
-1.28%
After Hours: 10.14 +0.13 +1.30% 19:49 02/06 EST
OPEN
10.14
PREV CLOSE
10.14
HIGH
10.14
LOW
9.12
VOLUME
414.45K
TURNOVER
--
52 WEEK HIGH
12.09
52 WEEK LOW
0.8786
MARKET CAP
369.37M
P/E (TTM)
-17.4451
1D
5D
1M
3M
1Y
5Y
1D
Adlai Nortye Secures $140 Million PIPE Financing to Support Oncology Pipeline
TipRanks · 3d ago
Adlai Nortye Raises $140 Million in Private Placement Equity Financing
Reuters · 3d ago
Adlai Nortye kündigt Privatplatzierung über 140 Millionen US-Dollar an
Reuters · 3d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 3d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 4d ago
Adlai Nortye Announces $140M Private Placement Equity Financing
Benzinga · 4d ago
Adlai Nortye jumps 25%, raises $140M via private placement
Seeking Alpha · 4d ago
Adlai Nortye prices 64.6M shares at $2.17 in private placement
TipRanks · 4d ago
More
About ANL
Adlai Nortye Ltd. is a Cayman Islands-based investment holding company. The Company is involved in the research and development of pharmaceutical products. It is a clinical-stage company focused on the development of targeted and immune-modulating cancer therapies. It is advancing an oncology pipeline, with Buparlisib (AN2025), a pan-phosphoinositide 3-kinase (PI3K) inhibitor, being evaluated in a registrational Phase three trial (NCT04338399) for patients with recurrent or metastatic head and neck squamous cell cancer (HNSCC) that has progressed after prior anti-programmed death-ligand 1 (PD-L1) treatment. It is also advancing multiple drug candidates, including AN4005, an oral small molecule PD-L1 inhibitor; AN8025, a multifunctional fusion protein acting as a T cell and antigen-presenting cell (APC) modulator; and AN9025, an oral small molecule pan-rat sarcoma virus (RAS) inhibitor. The Company’s subsidiary, Alpine Bioscience Ltd. (Alpine BVI), is an investment holding company.

Webull offers Adlai Nortye Ltd (ADR) stock information, including NASDAQ: ANL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANL stock methods without spending real money on the virtual paper trading platform.